Eli Lilly (LLY 0.76%) is one of the most prominent drugmakers on the globe. However, with a market cap exceeding $62 billion and product offerings in a wide range of therapeutic areas, it can be difficult for investors to understand every aspect of its business. In this segment, health care analyst Max Macaluso takes a close look at a specific division that generated more than $2 billion in revenue last year but that many Lilly investors might not know about: animal health.
1 Eli Lilly Division That Roared Into 2013
By Max Macaluso – Feb 19, 2013 at 6:30PM
NYSE: LLY
Eli Lilly
Market Cap
$782B
Today's Change
(-0.76%) $6.31
Current Price
$820.10
Price as of October 28, 2025 at 4:00 PM ET
The animal health business drives growth, but not many investors know about it.
About the Author
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
Follow @TMFMassimo